Guillain–Barre syndrome - clinical profile, diagnosis and recovery in a tertiary care setting

Dipali Y. Uikey; Anita Paritekar

doi:10.18203/2320-6012.ijrms20253604

Authors

Dipali Y. Uikey Rajarshree Chattrapati Shahu Maharaj Government Medical College and Chhatrapati Pramilatai Raje Hospital, Kolhapur, Maharashtra, India
Anita Paritekar Rajarshree Chattrapati Shahu Maharaj Government Medical College and Chhatrapati Pramilatai Raje Hospital, Kolhapur, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20253604

Keywords:

Acute motor axonal neuropathy, Guillain–Barre syndrome

Abstract

Background: Guillain–Barre syndrome (GBS) is an autoimmune disease and a recognized cause of generalized progressive paralysis worldwide. The present study was aimed to document the clinical finding, diagnostic challenges, and management outcome amongst the patients with GBS during the hospital stay.

Methods: A retrospective analysis of 22 cases diagnosed as GBS was conducted. Medical records and the data related to age, sex, antecedent illness, muscle power graded by the Medical Research Council scale, functional scores, details of intensive care unit complications and need for ventilation were obtained.

Results: GBS seems to affect all age groups with male preponderance. The male-to female ratio was 2.5:1. Maximum number of patients (50 %, n=11) were in the age group of 60 years and above. The next common age group was 13-30 years in which 31.8% (n=7) patient. Nearly 72% patients (n=16) had history of preceding illness. Paraparesis as a common clinical feature 54.5% (n=12). The majority (n=20) 90.9% were found to be of AMSAN followed by AIDP variants (n=2) 9.09%. About 59.09% patient (n=13) improved at the time of discharge on their F-scores with mild disability.

Conclusions: GBS remains a neurologic emergency that requires early recognition and prompt management to improve patient outcomes. Our study highlights the diverse clinical presentations and underscores the importance of supportive care and timely initiation of immunotherapy. While most patients show favourable recovery with appropriate treatment, residual deficits and complications can persist, emphasizing the need for ongoing rehabilitation and follow-up. Increased awareness among clinicians, especially in primary care and emergency settings, is crucial for early diagnosis. Further research is warranted to explore predictive markers of prognosis and optimize long-term care strategies.

Metrics

Metrics Loading ...

References

Ropper AH, Samuels M. Adams and Victor’s principles of neurology. New York: McGraw-Hill Medical Publishing Division. 2005;1117-27.

Gorson KC, Ropper AH. Guillain-Barré syndrome (acute inflammatory demyelinating polyneuropathy) and related disorders. In: Katirji B, Kaminski HJ, Preston DC, editors. Neuromuscular disorders in clinical practice. Boston: Butterworth-Heinemann. 2002:544-66.

Burns TM. Guillain-Barré syndrome. Semin Neurol. 2008;28:152-67. DOI: https://doi.org/10.1055/s-2008-1062261

van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol. 2008;7:939-50. DOI: https://doi.org/10.1016/S1474-4422(08)70215-1

Rees JH, Soudain SE, Gregson NA, Hughes RA. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med. 1995;333:1374-9. DOI: https://doi.org/10.1056/NEJM199511233332102

Kalita J, Misra UK, Goyal G, Das M. Guillain-Barré syndrome: subtypes and predictors of outcome from India. J Peripher Nerv Syst. 2014;19:36-43. DOI: https://doi.org/10.1111/jns5.12050

Sivadon-Tardy V, Orlikowski D, Porcher R, Sharshar T, Durand MC, Enouf V, et al. Guillain-Barré syndrome and influenza virus infection. Clin Infect Dis. 2009;48:48-56. DOI: https://doi.org/10.1086/594124

Larsen JP, Kvåle G, Nyland H. Epidemiology of the Guillain-Barré syndrome in the county of Hordaland, Western Norway. Acta Neurol Scand. 1985;71:43-7. DOI: https://doi.org/10.1111/j.1600-0404.1985.tb03165.x

Zaheer M, Naeem M, Nasrullah M. Seasonal variation and sex distribution in patients with Guillain-Barré syndrome. Pak J Neurol Sci. 2008;3:6-8.

Sharma G, Sood S, Sharma S. Seasonal, age and gender variation of Guillain-Barré syndrome in a tertiary referral center in India. Neurosci Med. 2013;4:23. DOI: https://doi.org/10.4236/nm.2013.41004

Hughes RA, Swan AV, Raphaël JC, Annane D, van Koningsveld R, van Doorn PA. Immunotherapy for Guillain-Barré syndrome: a systematic review. Brain. 2007;130(9):2245-57. DOI: https://doi.org/10.1093/brain/awm004

Raphaël JC, Chevret S, Hughes RA, Annane D. Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2012;7:CD001798. DOI: https://doi.org/10.1002/14651858.CD001798.pub2

Hughes RA, Wijdicks EF, Benson E, Cornblath DR, Hahn AF, Meythaler JM, et al. Supportive care for patients with Guillain-Barré syndrome. Arch Neurol. 2005;62:1194-8. DOI: https://doi.org/10.1001/archneur.62.8.1194

Medical Research Council. Aids to the investigation of the peripheral nervous system. London: HMSO; 1943.

Hughes RAC, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial of prednisolone in acute polyneuropathy. Lancet. 1978;2:750-3. DOI: https://doi.org/10.1016/S0140-6736(78)92644-2

Sriganesh K, Netto A, Kulkarni GB, Taly AB, Umamaheswara Rao GS. Seasonal variation in the clinical recovery of patients with Guillain-Barré syndrome requiring mechanical ventilation. Neurol India. 2013;61:349-54. DOI: https://doi.org/10.4103/0028-3886.117582

McGrogan A, Madle GC, Seaman HE, de Vries CS. The epidemiology of Guillain-Barré syndrome worldwide: a systematic literature review. Neuroepidemiology. 2009;32:150-63. DOI: https://doi.org/10.1159/000184748

van Koningsveld R, Rico R, Gerstenbluth I, Schmitz PI, Ang CW, Merkies IS, et al. Gastroenteritis-associated Guillain-Barré syndrome on the Caribbean Island Curaçao. Neurology. 2001;56:1467-72. DOI: https://doi.org/10.1212/WNL.56.11.1467

Nachamkin I, Arzarte Barbosa P, Ung H, Lobato C, Gonzalez Rivera A, Rodriguez P, et al. Patterns of Guillain-Barré syndrome in children: results from a Mexican population. Neurology. 2007;69:1665-71. DOI: https://doi.org/10.1212/01.wnl.0000265396.87983.bd

Gupta D, Nair M, Baheti NN, Sarma PS, Kuruvilla A. Electrodiagnostic and clinical aspects of Guillain-Barré syndrome: an analysis of 142 cases. J Clin Neuromuscul Dis. 2008;10:42-51. DOI: https://doi.org/10.1097/CND.0b013e31818e9510

Sharma A, Lal V, Modi M, Vaishnavi C, Prabhakar S. Campylobacter jejuni infection in Guillain-Barré syndrome: a prospective case-control study in a tertiary care hospital. Neurol India. 2011;59:717-21. DOI: https://doi.org/10.4103/0028-3886.86547

Kannan MA, Ch RK, Jabeen SA, Mridula KR, Rao P, Borgohain R. Clinical, electrophysiological subtypes and antiganglioside antibodies in childhood Guillain-Barré syndrome. Neurol India. 2011;59:727-32. DOI: https://doi.org/10.4103/0028-3886.86549

Islam Z, Jacobs BC, van Belkum A, Mohammad QD, Islam MB, Herbrink P, et al. Axonal variant of Guillain-Barré syndrome associated with Campylobacter infection in Bangladesh. Neurology. 2010;74:581-7. DOI: https://doi.org/10.1212/WNL.0b013e3181cff735

Borhani Haghighi A, Banihashemi MA, Zamiri N, Sabayan B, Heydari ST, Safari A, et al. Seasonal variation of Guillain-Barré syndrome admission in a large tertiary referral center in Southern Iran: a 10-year analysis. Acta Neurol Taiwan. 2012;21:60-3.

Orlikowski D, Prigent H, Sharshar T, Lofaso F, Raphael JC. Respiratory dysfunction in Guillain-Barré syndrome. Neurocrit Care. 2004;1:415-22. DOI: https://doi.org/10.1385/NCC:1:4:415

Winer JB, Hughes RAC, Greenwood RJ, Perkin GD, Healy MJR. Prognosis in Guillain-Barré syndrome. Lancet. 1985;1:1202-3. DOI: https://doi.org/10.1016/S0140-6736(85)92875-2

Kaya E, Keklik M, Sencan M, Yilmaz M, Keskin A, Kiki I, et al. Therapeutic plasma exchange in patients with neurological diseases: multicenter retrospective analysis. Transfus Apher Sci. 2013;48:349-52. DOI: https://doi.org/10.1016/j.transci.2013.04.015